Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury
NCT03431194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2022-08-22
Summary
The aim of this randomized trial was to assess the efficacy of oral midodrine tablets for the management of intradialytic hypotension among critically ill patients with acute kidney injury.
Conditions
Interventions
- DRUG
-
midodrine
oral midodrine tablets 5 mg
- DRUG
Sponsors & Collaborators
-
New Jeddah Clinic Hospital
collaborator INDUSTRY -
Benha University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-01
- Primary Completion
- 2017-02-19
- Completion
- 2017-04-06
More Related Trials
-
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
NCT01309724 ·Status: COMPLETED ·Phase: NA
-
Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients
NCT00298454 ·Status: TERMINATED ·Phase: PHASE3
-
Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury
NCT04215042 ·Status: UNKNOWN ·Phase: NA
-
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
NCT01393782 ·Status: COMPLETED ·Phase: PHASE1
-
Vasoactive Drugs in Intensive Care Unit
NCT02118467 ·Status: RECRUITING ·Phase: PHASE4
-
An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty
NCT02154243 ·Status: TERMINATED ·Phase: NA
-
The Furosemide Stress Test, Electrolytes Response and Renal Index in Critically Ill Patients
NCT04215419 ·Status: COMPLETED
-
Automated Abdominal Binder for Orthostatic Hypotension
NCT03482297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Dose Vasopressin in Traumatic Shock
NCT00420407 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children
NCT01301274 ·Status: COMPLETED ·Phase: NA
-
Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill
NCT02860572 ·Status: COMPLETED ·Phase: NA
-
Methoxyflurane and Fentanyl in LBNP
NCT04641949 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
NCT00113685 ·Status: COMPLETED ·Phase: NA
-
Response of Pulse Pressure Variation in PA Catheter Tracing to IV Fluid Bolus in the ICU
NCT02419404 ·Status: COMPLETED
-
Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension
NCT01520207 ·Status: COMPLETED ·Phase: PHASE2
-
Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults
NCT05933642 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dynamic Arterial Elastance as a Predictor of Arterial Blood Pressure Response to Fluid Administration in Septic Patients
NCT03179215 ·Status: COMPLETED
-
Dopamine and Norepinephrine Infusion With Restricted Hydration
NCT03780686 ·Status: COMPLETED ·Phase: NA
-
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
NCT01611935 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients
NCT01072071 ·Status: UNKNOWN ·Phase: NA
-
Small Volume Fluid Challenge as a Predictor of Fluid Responsiveness in Patients With Circulatory Failure
NCT03622099 ·Status: COMPLETED
-
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
NCT06464510 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Starting Dose of Vasopressor on Hemodynamic Response in Shock
NCT06481839 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Midodrine Versus Albumin for Prevention of Paracentesis Induced Circulatory Disturbance
NCT05240391 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Citrate-based Anticoagulation With Calcium-free Phosphate-containing Fluid in Renal Replacement Therapy
NCT04215965 ·Status: UNKNOWN ·Phase: PHASE4